Authors: Todaro, Juliana, Bigonha, Jandey, Borducchi, Davimar Miranda Maciel, Matos, Leandro Luongo, Trufelli, Damila Cristina, Sales, Suzane Martines Alves de, Shiroma, Marina Rampazzo Del Valhe, Giglio, Auro del
Source: einstein (São Paulo). June 2011 9(2)
Subject Terms: Multiple myeloma/therapy, Neoplasm staging, Survival
File Description: text/html
Authors: Rita Rizzi, Pellegrino Musto, Renato Zambello, Gregorio Barilà
Source:
Pharmaceuticals
Pharmaceuticals, Vol 14, Iss 40, p 40 (2021)
Subject Terms: Drug Discovery, Pharmaceutical Science, Molecular Medicine, Medicine, business.industry, business, Cancer research, Drug, media_common.quotation_subject, media_common, Immunotherapy, medicine.medical_treatment, Multiple myeloma, medicine.disease, Off the shelf, Monoclonal antibody, medicine.drug_class, Neoplastic Plasma Cell, Advanced disease, Bispecific antibody, Review, immunotherapy, antibodies drug conjugated, bispecific antibodies, multiple myeloma therapy, lcsh:Medicine, lcsh:R, lcsh:Pharmacy and materia medica, lcsh:RS1-441
Access URL:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8aa663d41fd024a361926841a59938a4
https://www.mdpi.com/1424-8247/14/1/40/pdf
Authors: Alberto L. Horenstein, Antonella Chillemi, Fabio Malavasi, Valeria Quarona, Luca Antonioli, Davide Ferrari
Source: Frontiers in Immunology
Subject Terms: Immunology, Immunology and Allergy, ectoenzymes, adenosine, multiple myeloma therapy, microvesicles, CD38, Perspective, In vitro, Bone marrow, medicine.anatomical_structure, medicine, Immune system, Receptor, In vivo, Inflammation, medicine.symptom, Cell biology, Biology, Microvesicles, NO, Adenosine, Ectoenzymes, Multiple myeloma therapy
Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc2b7941be782940c8ac2e8a03768bf0
Authors: Bruno, Benjamin, De Ramon Ortiz, Carmen Julia, Ligozat, Sarah, Samii, Kaveh, Chevalley, Thierry
Source: Revue médicale suisse, Vol. 15, No 670 (2019) pp. 2032-2038
Subject Terms: ddc:616, ddc:618.97, Aged, Aged, 80 and over, Clinical Decision-Making, Geriatric Assessment, Humans, Multiple Myeloma/therapy
Access URL:
https://explore.openaire.eu/search/publication?articleId=od______1400::e7efa7a380f49479d0d01f76e48304e8
https://archive-ouverte.unige.ch/unige:143925
Authors: Leandro Luongo de Matos, Jandey Bigonha, Suzane Martines Alves de Sales, Damila Cristina Trufelli, Juliana Todaro, Marina Rampazzo Del Valhe Shiroma, Davimar Miranda Maciel Borducchi, Auro Del Giglio
Source:
Einstein (São Paulo) v.9 n.2 2011
Einstein (São Paulo)
IIEPAE
instacron:IIEPAE
Einstein (São Paulo), Volume: 9, Issue: 2, Pages: 145-150, Published: JUN 2011
Einstein (São Paulo), Vol 9, Iss 2, Pp 145-150 (2011)
Subject Terms: General Medicine, Gynecology, medicine.medical_specialty, medicine, Multiple myeloma, medicine.disease, business.industry, business, University hospital, Surgery, Staging system, Multiple myeloma/therapy, Neoplasm staging, Survival, Mieloma múltiplo/terapia, Estadiamento de neoplasias, Sobrevida, lcsh:Medicine, lcsh:R
File Description: text/html
Access URL:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72a3679407e1b8ca78a8b4d0a92ad53e
http://www.scielo.br/pdf/eins/v9n2/1679-4508-eins-9-2-0145.pdf
Authors: Sibel Hacioglu, Emre Tekgündüz, Mehmet Hilmi Dogu, Fevzi Altuntas, Hikmetullah Batgi, Irfan Kuku, Dicle İskender, Mehmet Ali Erkurt, Emin Kaya, Rafet Eren
Subject Terms: Aged, Female, Hematopoietic Stem Cell Mobilization/*methods, Humans, Male, Multiple Myeloma/*therapy, Apheresis, Mobilization, Multiple myeloma, antineoplastic agent, plerixafor, recombinant granulocyte colony stimulating factor, adult, aged, aging, Article, autologous hematopoietic stem cell transplantation, cancer chemotherapy, CD34 selection, cell kinetics, controlled study, drug megadose, female, groups by age, hematopoietic stem cell, human, major clinical study, male, middle aged, operation duration, patient selection, retrospective study, stem cell mobilization, procedures, Hematopoietic Stem Cell Mobilization, Hematology, Stem cell mobilization, Oncology, medicine.medical_specialty, medicine, Internal medicine, Autologous hsct, CD34, business.industry, business, medicine.disease, Stem cell, Procedure Duration, Age groups
Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2abbd722323b97b181c5203f2aa5d41c
Authors: McCarthy, Philip L., Holstein, Sarah A., Petrucci, Maria Teresa, Richardson, Paul G., Hulin, Cyrille, Tosi, Patrizia, Bringhen, Sara, Musto, Pellegrino, Anderson, Kenneth C., Caillot, Denis, Gay, Francesca, Moreau, Philippe, Marit, Gerald, Jung, Sin-Ho, Yu, Zhinuan, Winograd, Benjamin, Knight, Robert D., Palumbo, Antonio, Attal, Michel
Contributors: Roswell Park Cancer Institute [Buffalo], University of Nebraska Medical Center, University of Nebraska System, Università degli Studi di Roma 'La Sapienza' = Sapienza University [Rome], Dana-Farber Cancer Institute [Boston], CHU Bordeaux [Bordeaux], Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Hôtel-Dieu de Nantes, Duke University [Durham], Celgene Corporation, Institut Universitaire du Cancer de Toulouse - Oncopole (IUCT Oncopole - UMR 1037), CHU Toulouse [Toulouse]-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)
Source:
Journal of Clinical Oncology
Journal of Clinical Oncology, American Society of Clinical Oncology, 2017, 35 (29), pp.3279-3289. ⟨10.1200/JCO.2017.72.6679⟩
Subject Terms: MESH: Angiogenesis Inhibitors/administration & dosage, MESH: Thalidomide/analogs & derivatives, MESH: Multiple Myeloma/therapy, [SDV.CAN]Life Sciences [q-bio]/Cancer, Adult, Aged, Angiogenesis Inhibitors, Chemotherapy, Adjuvant, Disease Progression, Disease-Free Survival, Drug Administration Schedule, Female, Humans, Kaplan-Meier Estimate, Lenalidomide, Maintenance Chemotherapy, Male, Middle Aged, Multiple Myeloma, Randomized Controlled Trials as Topic, Risk Factors, Thalidomide, Time Factors, Transplantation, Autologous, Treatment Outcome, Young Adult, Stem Cell Transplantation, Cancer Research, Oncology, medicine.drug, medicine, business.industry, business, medicine.medical_specialty, Maintenance therapy, Multiple myeloma, medicine.disease, Randomized controlled trial, law.invention, law, Transplantation, Autologous stem-cell transplantation, Clinical endpoint, Internal medicine, ORIGINAL REPORTS
Access URL:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00c90cd491ac014a1bbef57b2f6073ac
https://hal-univ-bourgogne.archives-ouvertes.fr/hal-01697539
Authors: Moreau, Philippe, Attal, Michel, Caillot, Denis, Macro, Margaret, Karlin, Lionel, Garderet, Laurent, Facon, Thierry, Benboubker, Lotfi, Escoffre-Barbe, Martine, Stoppa, Anne-Marie, Laribi, Kamel, Hulin, Cyrille, Perrot, Aurore, Marit, Gerald, Eveillard, Jean-Richard, Caillon, Florence, Bodet-Milin, Caroline, Pegourie, Brigitte, Dorvaux, Veronique, Chaleteix, Carine, Anderson, Kenneth, Richardson, Paul, Munshi, Nikhil C., Avet-Loiseau, Herve, Gaultier, Aurelie, Nguyen, Jean-Michel, Dupas, Benoit, Frampas, Eric, Kraeber-Bodere, Françoise
Contributors: Centre hospitalier universitaire de Nantes (CHU Nantes), CHU Toulouse [Toulouse], Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN), Centre Hospitalier Lyon Sud [CHU - HCL] (CHLS), Hospices Civils de Lyon (HCL), CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université, Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), CHU Trousseau [Tours], Centre Hospitalier Régional Universitaire de Tours (CHRU Tours), CHU Pontchaillou [Rennes], Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC), Centre Hospitalier Le Mans (CH Le Mans), CHU Bordeaux [Bordeaux], Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Centre Hospitalier Régional Universitaire de Brest (CHRU Brest), Centre Hospitalier Universitaire [Grenoble] (CHU), Centre hospitalier régional Metz-Thionville (CHR Metz-Thionville), CHU Clermont-Ferrand, Dana-Farber Cancer Institute [Boston]
Source:
Journal of Clinical Oncology
Journal of Clinical Oncology, American Society of Clinical Oncology, 2017, 35 (25), pp.2911-2918. ⟨10.1200/JCO.2017.72.2975⟩
Subject Terms: ORIGINAL REPORTS, MESH: Adult, MESH: Aged, MESH: Magnetic Resonance Imaging/methods, MESH: Male, MESH: Middle Aged, MESH: Multiple Myeloma/diagnostic imaging, MESH: Multiple Myeloma/therapy, MESH: Positron Emission Tomography Computed Tomography/methods, MESH: Prospective Studies, MESH: Radiopharmaceuticals, MESH: Stem Cell Transplantation/methods, MESH: Survival Rate, MESH: Antineoplastic Combined Chemotherapy Protocols/therapeutic use, MESH: Bone Neoplasms/diagnosis, MESH: Bone Neoplasms/diagnostic imaging, MESH: Disease-Free Survival, MESH: Female, MESH: Fluorodeoxyglucose F18, MESH: Humans, [SDV.CAN]Life Sciences [q-bio]/Cancer
Access URL:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::ba09eae100c3709d9d813ad04d959e48
https://europepmc.org/articles/PMC5578392/
Authors: Ulrich Mey, Urs Hess, Dominik Heim, Daniel Betticher, Christoph Renner, Thilo Zander, Panagiotis Samaras, Erika Lerch, Mario Bargetzi, Christian Taverna, Thomas Pabst, Thomas Matthes, Michel A. Duchosal, Nicolas Ketterer
Source:
Swiss Medical Weekly, Vol. 145 (2015) P. w14100
Samaras, Panagiotis; Bargetzi, Mario; Betticher, Daniel C; Duchosal, Michel A; Heim, Dominik; Hess, Urs; Ketterer, Nicolas; Lerch, Erika; Matthes, Thomas; Mey, Ulrich; Pabst, Thomas; Taverna, Christian; Zander, Thilo; Renner, Christoph (2015). Current status and updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland. Swiss Medical Weekly, 145:w14100.
Samaras, Panagiotis; Bargetzi, Mario; Betticher, Daniel C; Duchosal, Michel A; Heim, Dominik; Hess, Urs; Ketterer, Nicolas; Lerch, Erika; Matthes, Thomas; Mey, Ulrich; Pabst, Thomas; Taverna, Christian; Zander, Thilo; Renner, Christoph (2015). Current status and updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland. Swiss medical weekly, 145, w14100. EMH Schweizerischer Ärzteverlag 10.4414/smw.2015.14100 <http://dx.doi.org/10.4414/smw.2015.14100>
Swiss Medical Weekly, vol. 145, pp. w14100
Subject Terms: ddc:616, 610 Medicine & health, General Medicine, Medicine, business.industry, business, Relapsed refractory, Internal medicine, medicine.medical_specialty, Median survival, Lenalidomide, medicine.drug, Multiple myeloma, medicine.disease, Oncology, Thalidomide, Bortezomib, Quality of life, Plasma Cell Myeloma, Clinic for Oncology and Hematology, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Monoclonal Gammopathy of Undetermined Significance/pathology, Multiple Myeloma/diagnosis, Multiple Myeloma/therapy, hemic and lymphatic diseases
File Description: application/pdf
Access URL:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bc6d99b0f20984244ead3e386f7efc0
https://archive-ouverte.unige.ch/unige:79945
Authors: Peters, Sebastian
Contributors: Horger, M.S. (Prof. Dr.)
Subject Terms: Plasmozytom , Computertomographie , Bortezomib, Multiples Myelom , Therapieresponsemonitoring , Multidetektor-Computertomographie , Bortezomib-Therapie , Pathologische Frakturen, Multiple myeloma , Therapy response monitoring , Multidetector computer tomography , Bortezomib-based therapy , Pathologic fractures
File Description: application/pdf
Access URL: https://explore.openaire.eu/search/publication?articleId=od_______707::8840cc1e12a3e6a217dde2a246dcf48d
Authors: S. Van Segbroeck, Jorge M. Pacheco, Francisco C. Santos, Fabio A. C. C. Chalub, David Dingli
Contributors: DM - Departamento de Matemática, CMA - Centro de Matemática e Aplicações
Source:
British Journal of Cancer, 101 (7
British Journal of Cancer
Subject Terms: Sciences bio-médicales et agricoles, Game Theory, Humans, Multiple Myeloma -- pathology, Multiple Myeloma -- therapy, Phenotype, Selection, Genetic, in-vivo, multiple-myeloma, game, inflammatory, cell, dynamics, ecology, myeloma, of, protein, tumor-cells, somatic, bone-disease, staging, 1-alpha, multiple, inhibition, evolution, system, transplantation, replicator, cancer, growth, evolutionary, osteoprotegerin, theory, Cancer dynamics, Cancer ecology, Evolutionary game theory of cancer, Multiple myeloma, Replicator cell dynamics, Somatic evolution of cancer, SDG 3 - Good Health and Well-being, Molecular Diagnostics, somatic evolution of cancer, multiple myeloma, cancer dynamics, replicator cell dynamics, cancer ecology, evolutionary game theory of cancer, Cancer Research, Oncology, Cancer cell, Natural selection, medicine.disease, medicine, Cancer, Computational biology, Transplantation, Genetic variation, Biology, Disease, Genetics
File Description: 1 full-text file(s): application/pdf
Access URL:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::291aa79259b44e7aa9550684ae49ad51
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/70934
Authors: De Prijck, Bernard, Baron, Frédéric, Beguin, Yves, Bonnet, Christophe, Willems, Evelyne, Fillet, Georges
Source: Revue Médicale de Liège, 62(5-6), 384-90. Belgium (2007).
Subject Terms: Hematologic Neoplasms/therapy, Hematopoietic Stem Cell Transplantation, Humans, Leukemia, Myelogenous, Chronic, BCR-ABL Positive/therapy, Multiple Myeloma/therapy, Hematology [Human health sciences], Hématologie [Sciences de la santé humaine], hemic and lymphatic diseases, immune system diseases, Human health sciences, Hematology, Sciences de la santé humaine, Hématologie
Access URL:
https://explore.openaire.eu/search/publication?articleId=od______1318::0419486ff9adbdf49c1286ea949c35aa
https://orbi.uliege.be/handle/2268/6979
Authors: Barilà G; Department of Medicine (DIMED), Hematology and Clinical Immunology Section, Padova University School of Medicine, 35121 Padova, Italy., Rizzi R; Department of Emergency and Organ Transplantation, 'Aldo Moro' University School of Medicine, 70121 Bari, Italy., Zambello R; Department of Medicine (DIMED), Hematology and Clinical Immunology Section, Padova University School of Medicine, 35121 Padova, Italy., Musto P; Department of Emergency and Organ Transplantation, 'Aldo Moro' University School of Medicine, 70121 Bari, Italy.; Unit of Hematology and Stem Cell Transplantation, AOUC Policlinico, 70124 Bari, Italy.
Source: Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2021 Jan 07; Vol. 14 (1). Date of Electronic Publication: 2021 Jan 07.
Publication Type: Journal Article; Review
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238453 Publication Model: Electronic Cited Medium: Print ISSN: 1424-8247 (Print) Linking ISSN: 14248247 NLM ISO Abbreviation: Pharmaceuticals (Basel) Subsets: PubMed not MEDLINE
Authors: Cook G; Leeds Institute of Clinical Trial research & Leeds Cancer Centre, University of Leeds, Leeds, UK., Morris CTCM; College of Myeloma (UK), UK Myeloma Forum, London, UK.
Source: British journal of haematology [Br J Haematol] 2020 Nov; Vol. 191 (4), pp. 542-551.
Publication Type: Journal Article; Review
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE
MeSH Terms: Multiple Myeloma/*epidemiology , Multiple Myeloma/*therapy, Disease Management ; Disease Susceptibility ; Humans ; Multiple Myeloma/etiology ; Outcome Assessment, Health Care ; United Kingdom/epidemiology
Authors: Wongsaengsak S; Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA., Kopel J; School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA., Behera TR; Department of Hematology and Medical Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA., Chakraborty R; Department of Hematology and Medical Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA., Ball S; Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
Source: British journal of haematology [Br J Haematol] 2020 Jul; Vol. 190 (2), pp. e95-e97. Date of Electronic Publication: 2020 May 13.
Publication Type: Letter; Meta-Analysis; Systematic Review
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE
MeSH Terms: Multiple Myeloma/*complications , Oligopeptides/*adverse effects , Proteasome Inhibitors/*adverse effects, Aged ; Humans ; Middle Aged ; Multiple Myeloma/drug therapy ; Randomized Controlled Trials as Topic
Authors: Chillemi A; Laboratory of Immunogenetics and CeRMS, Department of Medical Sciences, University of Torino , Torino , Italy., Quarona V; Laboratory of Immunogenetics and CeRMS, Department of Medical Sciences, University of Torino , Torino , Italy., Antonioli L; Department of Clinical and Experimental Medicine, University of Pisa , Pisa , Italy., Ferrari D; Department of Life Science and Biotechnology, University of Ferrara , Ferrara , Italy., Horenstein AL; Laboratory of Immunogenetics and CeRMS, Department of Medical Sciences, University of Torino , Torino , Italy., Malavasi F; Laboratory of Immunogenetics and CeRMS, Department of Medical Sciences, University of Torino , Torino , Italy.
Source: Frontiers in immunology [Front Immunol] 2017 Mar 20; Vol. 8, pp. 305. Date of Electronic Publication: 2017 Mar 20 (Print Publication: 2017).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Print ISSN: 1664-3224 (Print) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: PubMed not MEDLINE
Additional Titles: CUHK electronic theses & dissertations collection
Index Terms: Multiple myeloma--Treatment, Anticoagulants (Medicine), Blood--Coagulation, Multiple Myeloma--therapy, Platelet Factor 4--antagonists & inhibitors, Text, bibliography
Additional Titles:
澳門治療多發性骨髓瘤的第一線治療方案之成本效益分析
Aomen zhi liao duo fa xing gu sui liu de di yi xian zhi liao fang an zhi cheng ben xiao yi fen xi
Index Terms: Multiple myeloma--Treatment, Medical care--Cost effectiveness, Medical care--China--Macau (Special Administrative Region)--Cost effectiveness, Multiple Myeloma--therapy, Cost-Benefit Analysis, Cost-Benefit Analysis--Macau, Text, bibliography
Source: British Journal of Cancer, 101 (7
Index Terms: Sciences bio-médicales et agricoles, Game Theory, Humans, Multiple Myeloma -- pathology, Multiple Myeloma -- therapy, Phenotype, Selection, Genetic, info:eu-repo/semantics/article, info:ulb-repo/semantics/articlePeerReview, info:ulb-repo/semantics/openurl/article
URL:
Source: Transfusion, 43 (1
Index Terms: Sciences bio-médicales et agricoles, Adult, Aged, Antineoplastic Agents -- therapeutic use, Breast Neoplasms -- therapy, Female, Filgrastim -- pharmacology, Hematopoietic Stem Cell Mobilization, Hematopoietic Stem Cell Transplantation -- adverse effects, Humans, Leukapheresis, Lymphoma -- therapy, Male, Middle Aged, Multiple Myeloma -- therapy, Transplantation, Autologous, info:eu-repo/semantics/article, info:ulb-repo/semantics/articlePeerReview, info:ulb-repo/semantics/openurl/article
URL: